Asensus Surgical

KARL STORZ acquired Asensus Surgical for $0.35 per share in cash, making Asensus a subsidiary. The deal closed after stockholder approval, combining Asensus's robotic surgery technology with KARL STORZ's endoscopy portfolio.

Asensus Surgical announced that The Rocky Mountain Hospital for Children in Denver, Colorado, has entered into an agreement to utilize a Senhance Surgical System, making it the first dedicated pediatric hospital in the US to use the system.

KARL STORZ Endoscopy-America, a subsidiary of KARL STORZ SE & Co. KG, will acquire all outstanding shares of Asensus Surgical for $0.35 per share in cash. The transaction is expected to close in Q3 2024.

Karl Storz has entered into a non-binding letter of intent to acquire Asensus Surgical, a surgical robot maker, for 35 cents per share in cash. The deal includes a bridge loan of up to $20 million.

Asensus Surgical has entered into a non-binding letter of intent with KARL STORZ SE & Co. KG for KARL STORZ to acquire 100% of Asensus common stock for $0.35 per share in cash, representing a 66.7% premium. A bridge loan of up to $20 million has been provided.

Asensus Surgical and KARL STORZ VentureONE signed a Memorandum of Understanding for KARL STORZ to market and sell Asensus' Intelligent Surgical Unit as a standalone device and collaborate on next-generation instrumentation.